Congratulations to Drs. Chavala and Mahato, Department of Pharmacology & Neuroscience, for receiving an award from the Glaucoma Research Foundation for $50,000.00, for their study entitled, “Chemically reprogrammed retinal ganglion cell therapy to treat glaucomatous neuropathy”.
For more details, please view the latest Monthly Research Report on our site, linked above.